dapsone

(redirected from Aczone)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to dapsone

antibacterial drug used to treat leprosy and some kinds of skin diseases

References in periodicals archive ?
Dapsone 7.5% gel, marketed as Aczone gel, 7.5% by Allergan, is a once-daily reformulation of the older 5% product administered twice daily.
Dapsone gel, 7.5%, marketed as Aczone gel, 7.5%, by Allergan, is a once-daily reformulation of the older 5% product administered twice daily.
Another option for consumers looking for acne relief comes from Allergan PLC, which launched Aczone Gel 7.5%, indicated for use by patients ages 12 and older.
Medications such as Aczone, Differin, Epiduo, Duac, Veltin and Acanya are analyzed, too.
For example, acne remedy Aczone thought it was putting two and two together when it decided to draw upon the success of High School Musical and Twilight to appeal to teens.
Others in this class include dapsone (Aczone), sulfadiazine and sulfasalazine (Azulfidine).
Although Allergan posted a solid 9% growth in reveneus in 2017, losses for the year include the impact of taxes paid in connection with the generic businesses sold to Teva Pharmaceuticals, and amortization of approximately $6.5 billion, primarily due to impairment charges recognized in 3Q17 of $3.2 billion related to Restasis and $646 million related to Aczone.
A sulfone drug, Aczone 5% gel has anti-inflammatory and antimicrobial properties.
M2 PHARMA-February 26, 2016-Allergan passes US FDA's approval for ACZONE Gel, 7.5% for treating acne in patients 12 years of age and older in once daily dosing
The favorable results of a phase IV safety study of the topical agent conducted in acne patients with known glucose 6-phosphate dehydrogenase deficiency recently persuaded the Food and Drug Administration to rescind its requirement that all acne patients be tested for G6PD deficiency before prescribing Aczone (dapsone gel).
Dirk Elston, director of the department of dermatology at Geisinger Medical Center in Danville, Pa., believes Aczone "should never have required the blood test" in the first place.